CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
IDL Biotech AB Company Snapshot
IDL Biotech AB operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares IDL Biotech AB with three other pharmaceutical manufacturers in Europe: Hemcheck Sweden AB (2017 sales of 10,000.00 Swedish Kronor [US$1,184.00 ] ), Epigenomics AG of Germany (1.86 million Euro [US$2.29 million] of which 68% was Licences), and RTA Laboratuvarlari Biyolojik Urunler Ilac Ve Makine Sanayi Ticaret AS which is based in Turkey (38.45 million Turkish Liras [US$9.43 million] ).

Sales Analysis. IDL Biotech AB reported sales of SEK 32.31 million (US$3.83 million) for the year ending December of 2017. This represents a decrease of 3.5% versus 2016, when the company's sales were SEK 33.49 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
IDL Biotech AB
  Stock Performance Chart for IDL Biotech AB
 
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 2.00
(Figures in Swedish Kronor)
1 Week -16.7%   13 Weeks -16.7%  
4 Weeks -20.0%   52 Weeks -27.3%  
 
IDL Biotech AB Key Data:
  Ticker: IDL B Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2017 Sales 32,311,899
(Year Ending Jan 2018).
Employees: 12
  Currency: Swedish Kronor Market Cap: 54,676,378
  Fiscal Yr Ends: December Shares Outstanding: 27,338,189
  Share Type: B Aktie Closely Held Shares: N/A
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.